ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

RENE Reneuron Group Plc

3.05
0.00 (0.00%)
13 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Reneuron Group Plc LSE:RENE London Ordinary Share GB00BF5G6K95 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.05 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 530k -5.41M -0.0946 -0.32 1.74M
Reneuron Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker RENE. The last closing price for Reneuron was 3.05p. Over the last year, Reneuron shares have traded in a share price range of 2.95p to 10.25p.

Reneuron currently has 57,173,760 shares in issue. The market capitalisation of Reneuron is £1.74 million. Reneuron has a price to earnings ratio (PE ratio) of -0.32.

Reneuron Share Discussion Threads

Showing 4826 to 4845 of 8900 messages
Chat Pages: Latest  200  199  198  197  196  195  194  193  192  191  190  189  Older
DateSubjectAuthorDiscuss
13/11/2015
12:13
it will be a private company with no pesky shareholders who will reap all the rewards five years down the line if they are ready by then to apply for fda approval on any successful therapies
rocket fuel
13/11/2015
12:02
The therapy is proven to work and.................answers on a postcard please
bigspuds
13/11/2015
10:30
rf - so I take it you're optimistic about the future for RENE :) ?
investordave
13/11/2015
10:22
should imagine they just got their ceo and cfo mixed up on that Biotech Capital Conference article.
there will be more pain to come here, the mkt cap will return to pre fundraising hype valuations of £80m. that is c2.5p and i believe it will eventually go sub 2p heading on a downward spiral into near administration before special deals are cut with city friends resulting in this one delisting and being taken private without a penny being returned to the beloved shareholders.

rocket fuel
13/11/2015
01:03
Post:4585 Norbus

"We are delighted to confirm the appointments of Julian and Shaun to our senior management team..."

Any connection with Julian and Sandy from "Round the Horne" I wonder.

This jreference is for the oldies on the thread!!

algernon2
12/11/2015
23:12
RF

Did you smell something ; you have been frighteningly right

The ex ceo Olav knows something they are a hiding? sounds like it; did they hide his departure?

norbus
12/11/2015
14:27
I missed that sale. How much were they offloaded for please?
investordave
12/11/2015
12:37
5 million sold after hours last night. Having cleared that sale I was expecting a bounce today. More in the wings?
dickbush
11/11/2015
16:40
Now that I checked, the following I cut and pasted out of an RNS 11th June


Olav Hellebø, Chief Executive Officer of ReNeuron, commented:

"We are delighted to confirm the appointments of Julian and Shaun to our senior management team. Their particular skills, experience and knowledge of the industry will be great assets to the business as we increase our clinical development activities internationally. The appointments further increase the breadth and depth of our executive management team as we evolve and transition the Company into its next stage of development as one of the leading players globally in its field."

,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,

MIKe hUNT maybe could not get on with his boss

So a likely reason for the drift in shares if the CEO supporters were selling

norbus
11/11/2015
15:01
interesting Norbus - the announcement before stated they were getting a CEO and Mike Hunt would move into Financial Director role if I remember correct...
stewart_25
11/11/2015
14:33
Michael Hunt, CEO,

What happened to the proper CEO they hired? maybe that is why the price has drifted; I never rated Mike Hunt

norbus
11/11/2015
13:35
Michael Hunt, CEO, will be presenting to investors at the Biotech Capital Conference on the 23rd November in London. To register to attend, please click here:
aim_trader
11/11/2015
08:45
Sad to say it Norbus, but he did call 3p! :-(
stewart_25
11/11/2015
08:32
Very soon, RF will come on to rightly claim he said it all along, which he did; I think 3p would be silly to miss
norbus
10/11/2015
16:44
Tempted at this price
richtea1701
10/11/2015
15:57
verger -I'm inclined to agree with you.
investordave
10/11/2015
14:50
We need some good news soon or we'll be below 3p a share.
investordave
10/11/2015
14:29
And another big drop ...
stewart_25
07/11/2015
19:00
Where investing is concerned, you can't beat cashflow positive and growing profits; did no harm to Warren Buffet; for jackpots you go to casinos in Las Vegas or Macao
norbus
06/11/2015
16:32
Mentioned in Moneyweek magazine. "Five game-changing technologies". Loss making but has enough cash to fund development
yachtmaster2
Chat Pages: Latest  200  199  198  197  196  195  194  193  192  191  190  189  Older

Your Recent History

Delayed Upgrade Clock